Bevacizumab and Lomustine for Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Amgen 386 for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
- Status
- TERMINATED
- Phase
- N/A
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE2
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BG & TMZ Therapy of Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dendritic Cell Cancer Vaccine for High-grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
Vitamin D for Treatment of Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of Steroid Tapering on Functional Capacity and Neurocognition
- Status
- WITHDRAWN
- Phase
- NA
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cellular Immunotherapy Study for Brain Cancer
- Status
- COMPLETED
- Phase
- PHASE1